Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase I trial of amuvatinib in patients with glioblastoma.

Trial Profile

Phase I trial of amuvatinib in patients with glioblastoma.

Phase of Trial: Phase I

Latest Information Update: 26 Sep 2012

At a glance

  • Drugs Amuvatinib (Primary)
  • Indications Glioblastoma
  • Focus Adverse reactions
  • Most Recent Events

    • 26 Sep 2012 Status changed from planning to discontinued prior to trial initiation.
    • 13 Aug 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top